Literature DB >> 12134111

Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2B.

Liise K Kayler1, Robert M Merion, Juan D Arenas, John C Magee, Darrell A Campbell, Steven M Rudich, Jeffrey D Punch.   

Abstract

Epithelioid hemangioendothelioma (EH) is a rare, low-grade, malignant neoplasm of vascular origin that may develop at different sites, such as in the soft tissue, lungs, or liver. We report the case of a 21-year-old female with primary EH of the liver treated by liver transplantation and review the available literature on EH. This patient developed symptomatic recurrence of the tumor in the pelvis 2 months posttransplant. Treatment with interferon alpha-2b resulted in substantial regression of the pelvic metastases and alleviation of symptoms, but the patient developed graft rejection and died of associated complications 16 months posttransplant. This report is the first showing the efficacy of interferon in this setting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134111     DOI: 10.1097/00007890-200207150-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

Review 1.  Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma.

Authors:  Augustine Lau; Steve Malangone; Myke Green; Ambuga Badari; Kathryn Clarke; Emad Elquza
Journal:  Ther Adv Med Oncol       Date:  2015-07       Impact factor: 8.168

Review 2.  Vascular sarcomas.

Authors:  Vinod Ravi; Shreyaskumar Patel
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

3.  Hepatic epithelioid hemangioendothelioma: Clinical characteristics, diagnosis, treatment, and prognosis.

Authors:  Man Zhao; Fei Yin
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

4.  Living donor liver transplantation for epithelioid hemangioendothelioma: Report of a case.

Authors:  Kiyoshi Hasegawa; Yasuhiko Sugawara; Mami Ikeda; Takeaki Ishizawa; Kenichi Ohashi; Masatoshi Makuuchi
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

5.  Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma.

Authors:  Maria Caterina Pallotti; Margherita Nannini; Claudio Agostinelli; Simona Leoni; Valerio Di Scioscio; Anna Mandrioli; Cristian Lolli; Maristella Saponara; Stefano Pileri; Luigi Bolondi; Guido Biasco; Maria Abbondanza Pantaleo
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 6.  Vascular tumours of the liver: a particular story.

Authors:  Jan Lerut; Samuele Iesari
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-14

7.  Multifocal and metastatic hepatic hemangioendothelioma: case report and literature review.

Authors:  Lucas Rios Torres; Luciana Sátiro Timbó; Cristiane Maria de Freitas Ribeiro; Mario Melo Galvão Filho; Carlos Gustavo Yuji Verrastro; Giuseppe D'Ippolito
Journal:  Radiol Bras       Date:  2014 May-Jun

8.  Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report.

Authors:  Sumit Gaur; Alireza Torabi; Thomas J O'Neill
Journal:  Cancer Biol Med       Date:  2012-06       Impact factor: 4.248

9.  Management of hepatic epithelioid haemangio-endothelioma in children: what option?

Authors:  K Sharif; M English; P Ramani; D Alberti; J-B Otte; P McKiernan; S Gosseye; M Jenney; J de Ville de Goyet
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

Review 10.  Hepatic Hemangioendothelioma: An update.

Authors:  Mayur Virarkar; Mohammed Saleh; Radwan Diab; Melissa Taggart; Peeyush Bhargava; Priya Bhosale
Journal:  World J Gastrointest Oncol       Date:  2020-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.